NSCLC	Non-small cell lung cancer
ICIs	Immune checkpoint inhibitors
PFS	Progression free survival
OS	Overall survival
EGFR	Epidermal growth factor receptor
ALK	Anaplastic lymphoma kinase
ROS1	ROS proto-oncogene 1
PD-1	Programmed death-1
PD-L1	PD-ligand 1
CTLA-4	cytotoxic T lymphocyte antigen 4
TME	Tumor microenvironment
VEGF	Vascular endothelial growth factor
APC	Antigen presenting cells
Tregs	Regulatory T cells
MDSCs	Myeloid-derived suppressive cells
TAMs	Tumor-associated macrophages
imDC	Immature dendritic cells
RET	Rearranged during transfection
TMB	Tumor mutation burden
HIF-1α	Hypoxia-inducible factor-1 alpha
IRRC	Independent Regulatory Review
FGF	Fibroblast growth factor
TKI	Tyrosine kinase inhibitor